Name: Ivermectin to Prevent Extinction (en Inglés)
Price: 18900.00 CLP
Availability: InStock
Author: Pascal, Charles
ISBN: 9781326770525

portada Ivermectin to Prevent Extinction (en Inglés)

Formato

Libro Físico

Autor

Charles Pascal

Editorial

Lulu.com

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.3 cm

Peso

0.08 kg.

ISBN13

9781326770525

Categorías

Salud pública y medicina preventiva

Ivermectin to Prevent Extinction (en Inglés)

Charles Pascal (Autor) · Lulu.com · Tapa Blanda

Libro Físico

$ 18.900

$ 37.790

Ahorras: $ 18.890

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 08 de Julio y el Jueves 18 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Ivermectin to Prevent Extinction (en Inglés)"

There seems to be a growing interest in a drug called ivermectin to treat humans with COVID-19. Ivermectin is often used in the U.S. to treat or prevent parasites in animals. The FDA has received multiple reports of patients who have required medical support and been hospitalized after self-medicating with ivermectin intended for horses. Ivermectin is a broad spectrum anti-parasitic agent, included in WHO essential medicines list for several parasitic diseases. It is used in the treatment of onchocerciasis (river blindness), strongyloidiasis and other diseases caused by soil transmitted helminthiasis. It is also used to treat scabies. A guideline development group was convened in response to the increased international attention on ivermectin as a potential treatment for COVID-19. This group is an independent, international panel of experts, which includes clinical care experts in multiple specialties and also includes an ethicist and patient-partners. The group reviewed pooled data from 16 randomized controlled trials (total enrolled 2407), including both inpatients and outpatients with COVID-19. They determined that the evidence on whether ivermectin reduces mortality, need for mechanical ventilation, need for hospital admission and time to clinical improvement in COVID-19 patients is of "very low certainty," due to the small sizes and methodological limitations of available trial data, including small number of events. GET YOUR COPY TODAY BY SCROLLING UP AND CLICKING BUY NOW TO GET YOUR COPY TODAY and say no to the apocalypse